A detailed history of Evoke Wealth, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Evoke Wealth, LLC holds 5,247 shares of NVO stock, worth $566,728. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,247
Holding current value
$566,728
% of portfolio
0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $624,760 - $763,018
5,247 New
5,247 $625 Million
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $15,316 - $20,387
-150 Reduced 3.21%
4,517 $579,000
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $141,676 - $170,196
1,614 Added 52.87%
4,667 $482,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $151,506 - $332,433
1,666 Added 120.12%
3,053 $277,000
Q2 2023

Aug 09, 2023

SELL
$155.98 - $172.65 $2,651 - $2,935
-17 Reduced 1.21%
1,387 $224,000
Q1 2023

May 08, 2023

BUY
$132.34 - $159.14 $185,805 - $223,432
1,404 New
1,404 $223,000
Q3 2022

Nov 07, 2022

SELL
$95.28 - $116.93 $13,910 - $17,071
-146 Reduced 18.23%
655 $65,000
Q2 2022

Aug 04, 2022

BUY
$103.24 - $121.81 $103 - $121
1 Added 0.13%
801 $89,000
Q1 2022

May 10, 2022

SELL
$93.1 - $112.54 $5,492 - $6,639
-59 Reduced 6.87%
800 $90,000
Q3 2021

Nov 12, 2021

BUY
$84.42 - $106.62 $12,240 - $15,459
145 Added 20.31%
859 $82,000
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $26,421 - $29,873
394 Added 123.13%
714 $49,000
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $127 - $140
-2 Reduced 0.62%
320 $22,000
Q2 2020

Aug 10, 2020

BUY
$58.54 - $67.94 $117 - $135
2 Added 0.63%
322 $21,000
Q4 2019

Feb 07, 2020

SELL
$49.86 - $58.26 $244,513 - $285,707
-4,904 Reduced 93.87%
320 $18.5 Million
Q3 2019

Nov 12, 2019

BUY
$47.54 - $53.43 $248,348 - $279,118
5,224 New
5,224 $270 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Evoke Wealth, LLC Portfolio

Follow Evoke Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evoke Wealth, LLC with notifications on news.